Virtual Medicinal Product (VMP) - Daunorubicin (liposomal) 50mg/25ml solution for infusion vials
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Daunorubicin (liposomal) 50mg/25ml solution for infusion vials | Start Date 28-03-2018 | End Date |
Previous Name | Previous Name Daunorubicin (liposomal) 50mg solution for infusion vials | Start Date 13-03-2018 |
End Date
|
Abbreviated Name | Abbreviated Name Daunorubicin (liposomal) 50mg/25ml inf vials | Start Date 28-03-2018 | |
Previous Abbreviated Name | Daunorubicin liposomal 50mg concentrate for IV infusion vls | Previous Start Date 15-07-2003 | Previous End Date 09-06-2004 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01DB02
BNF | Start Date | End Date |
---|---|---|
Current BNF 08010200 | Start Date 04-04-2022 | End Date |
Previous BNF 08010200 | Start Date 09-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
4694211000001102 | 15-07-2003 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Daunorubicin citrate liposomal | Based on Base Substance | Daunorubicin | 2 mg | 1 ml |
Name
Daunorubicin citrate liposomal
Basis of strength description
Based on Base Substance
BOSS
Daunorubicin
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMDaunorubicin (liposomal)
-
VMP(Current) Daunorubicin (liposomal) 50mg/25ml s...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 vial |